Histone H4 acetylation by immunohistochemistry and prognosis in newly diagnosed adult acute lymphoblastic leukemia (ALL) patients (Q33642213)

From Wikidata

Jump to navigation Jump to search

scientific article

edit

Language	Label	Description	Also known as
English	Histone H4 acetylation by immunohistochemistry and prognosis in newly diagnosed adult acute lymphoblastic leukemia (ALL) patients	scientific article

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20663136

retrieved

28 July 2017

title

Histone H4 acetylation by immunohistochemistry and prognosis in newly diagnosed adult acute lymphoblastic leukemia (ALL) patients (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20663136

retrieved

28 July 2017

main subject

immunohistochemistry

1 reference

based on heuristic

inferred from title

leukemia

1 reference

based on heuristic

inferred from title

lymphoblastic leukemia

1 reference

based on heuristic

inferred from title

author name string

Anjali S Advani

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20663136

retrieved

28 July 2017

Sarah E Gibson

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20663136

retrieved

28 July 2017

Elizabeth Douglas

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20663136

retrieved

28 July 2017

Tao Jin

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20663136

retrieved

28 July 2017

Xiaoxian Zhao

series ordinal

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20663136

retrieved

28 July 2017

Matt Kalaycio

series ordinal

6

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20663136

retrieved

28 July 2017

Ed Copelan

series ordinal

7

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20663136

retrieved

28 July 2017

Ronald Sobecks

series ordinal

8

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20663136

retrieved

28 July 2017

Mikkael Sekeres

series ordinal

9

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20663136

retrieved

28 July 2017

Shawnda Sungren

series ordinal

10

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20663136

retrieved

28 July 2017

Eric D Hsi

series ordinal

11

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20663136

retrieved

28 July 2017

language of work or name

English

0 references

publication date

21 July 2010

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20663136

retrieved

28 July 2017

published in

BMC Cancer

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20663136

retrieved

28 July 2017

volume

10

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20663136

retrieved

28 July 2017

page(s)

387

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20663136

retrieved

28 July 2017

describes a project that uses

immunohistochemistry

1 reference

based on heuristic

inferred from title

cites work

Histone tail modifications and noncanonical functions of histones: perspectives in cancer epigenetics

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2921396

retrieved

21 June 2018

Inhibition of histone deacetylation: a strategy for tumor radiosensitization

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2921396

retrieved

21 June 2018

Histone deacetylase (HDAC) inhibitor activation of p21WAF1 involves changes in promoter-associated proteins, including HDAC1

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2921396

retrieved

21 June 2018

Histone Deacetylases: Unique Players in Shaping the Epigenetic Histone Code

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2921396

retrieved

21 June 2018

Histone deacetylases (HDACs): characterization of the classical HDAC family

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2921396

retrieved

21 June 2018

Inhibition of transformed cell growth and induction of cellular differentiation by pyroxamide, an inhibitor of histone deacetylase

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2921396

retrieved

21 June 2018

Expression of the metastasis-associated MTA1 protein and its relationship to deacetylation of the histone H4 in esophageal squamous cell carcinomas

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1186%2F1471-2407-10-387

retrieved

21 January 2018

Histone deacetylase-1 and -3 protein expression in human breast cancer: a tissue microarray analysis

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1186%2F1471-2407-10-387

retrieved

21 January 2018

Global histone modification patterns predict risk of prostate cancer recurrence

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1186%2F1471-2407-10-387

retrieved

21 January 2018

A five-drug remission induction regimen with intensive consolidation for adults with acute lymphoblastic leukemia: cancer and leukemia group B study 8811.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2921396

retrieved

30 October 2018

Prognostic factors in a multicenter study for treatment of acute lymphoblastic leukemia in adults.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2921396

retrieved

30 October 2018

Erratum: Stock W, Johnson JL, Stone RM, Kolitz JE, Powell BL, Wetzler M, Westervelt P, Marcucci G, DeAngelo DJ, Vardiman JW, McDonnell D, Mrózek K, Bloomfield CD and Larson R A. Dose intensification of daunorubicin and cytarabine during treatment of

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/20663136

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prospective karyotype analysis in adult acute lymphoblastic leukemia: the cancer and leukemia Group B experience

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/20663136

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.1186/1471-2407-10-387

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20663136

retrieved

28 July 2017

Dimensions Publication ID

1044602939

0 references

PMC publication ID

2921396

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20663136

retrieved

28 July 2017

PubMed publication ID

20663136

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20663136

retrieved

28 July 2017

ResearchGate publication ID

45388102

0 references

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33642213&oldid=2195604300"